O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/17/2020ACC: 0001209191-20-064020
Officer· Chief Medical Officer
Since Jun 2018
+242.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
242.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+121.00
Price / share
$12.91
Trade value
$1.56K
% of position
4.2%
12/15/2020
2.88K→3K
Total
Net shares
+121.00
Net value
$1.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2020 | A · Award | +121.00 | $12.91 | $1.56K | 4.2% | 2.88K | 3K |
| Total | +121.00 | $1.56K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
121.00 shares
Shares
+121.00
Strike price
15.19
Held after
121.00
Exercisable
—
12/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock121.00 shares | 12/15/2020 | A · Award | +121.00 | 15.19 | — | 121.00 |